CTSO

Any way you look at it, it is most likely the world will be a different place once some sense of normality resumes …

While 2019’s market performance broke records, Wall Street is less optimistic about 2020. The pros foresee those gains leveling off in coming months …

The psychology of investing presents an interesting conundrum. When a stock soars, the natural tendency is to want to get in on the …

Optimistic views on Alzheimer remedy in its making by Anavex Life Sciences Corp (NYSE:AVXL) and improved earnings report by Cytosorbents Corp (NASDAQ:CTSO) caused analysts …

Following third quarter earnings, analysts are bullish on immunotherapy company Cytosorbents Corp (NASDAQ:CTSO) and EnteroMedics Inc (NASDAQ:ETRM) thanks to the companies’ cutting edge treatments. …

Recently, various executives have taken part in insider selling activity for the stocks of Athersys, Inc.(NASDAQ:ATHX), Neuralstem, Inc.

Recently, various executives have taken part in insider trading activity for the stocks of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Celgene Corporation (NASDAQ:CELG), Cytosorbents Corp (NASDAQ:CTSO), and Amedica Corporation (NASDAQ:AMDA). Synergy Pharmaceuticals Inc …

In a research report published Monday, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on shares of Cytosorbents Corp (NASDAQ:CTSO) with a $25 price …

Recently, various executives have taken part in insider selling activity for the stocks of GoPro Inc (NASDAQ:GPRO), Qorvo Inc (NASDAQ:QRVO), InvenSense Inc (NYSE:INVN), and Cytosorbents …

Brean Capital analyst Jonathan Aschoff came out today with a few insights on Cytosorbents Corp (NASDAQ:CTSO), after the company released its first-quarter results last week. …